chitosan has been researched along with mebendazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernandes Patta, ACM; Gama, GDS; Garcia, ITS; Gonçalves, JV; Mathews, PD; Mertins, O | 1 |
| Ghahremani, F; Hosseini, M; Jolfaie, NA; Kefayat, A; Rafienia, M | 1 |
2 other study(ies) available for chitosan and mebendazole
| Article | Year |
|---|---|
Targeted Drug Delivery and Treatment of Endoparasites with Biocompatible Particles of pH-Responsive Structure.
Topics: Alginates; Animals; Biocompatible Materials; Catfishes; Chitosan; Delayed-Action Preparations; Fish Diseases; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Ivermectin; Mebendazole; Parasitic Diseases | 2018 |
Biodegradable and biocompatible subcutaneous implants consisted of pH-sensitive mebendazole-loaded/folic acid-targeted chitosan nanoparticles for murine triple-negative breast cancer treatment.
Topics: Animals; Chitosan; Folic Acid; Humans; Hydrogen-Ion Concentration; Mebendazole; Mice; Nanoparticles; Triple Negative Breast Neoplasms | 2022 |